SEC Form 4 · accession 0001396677-16-000134
NUTRACEUTICAL INTERNATIONAL CORP · NUTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jeffrey A Hinrichs
Officer — EVP & COO · Director
Period of report
Dec 14, 2016
Accepted (ET)
Dec 16, 2016 · 12:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001050007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2016 | A | 3,478 | $34.50 | A | 233,860 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The acquisition reported in this Form 4 was a stock award under the Issuer's 2013 Long-Term Equity Incentive Plan approved by the Issuer's Compensation Committee on December 9, 2016 and granted on December 14, 2016. The stock award was fully vested on the date of the grant.